Table 2.
Control | 3 g/kg/d | 6 g/kg/d | 9 g/kg/d | P | |
---|---|---|---|---|---|
Glucose, mmol/l | 13.8 ± 1.4 | 14.1 ± 1.1 | 12.7 ± 0.9 | 13.4 ± 0.8 | 0.702 |
TAG, mmol/l | 2.05 ± 0.03 | 2.49 ± 0.33 | 2.48 ± 0.15 | 1.94 ± 0.21 | 0.126 |
Total cholesterol, mmol/l | 2.5 ± 0.1 | 2.4 ± 0.1 | 2.5 ± 0.1 | 2.2 ± 0.1a | 0.040 |
HDL-cholesterol, mmol/l | 1.90 ± 0.06 | 2.00 ± 0.13 | 1.99 ± 0.07 | 1.58 ± 0.08a | <0.0004 |
LDL-cholesterol, mmol/l | 0.18 ± 0.04 | 0.18 ± 0.01 | 0.13 ± 0.01a | 0.14 ± 0.01 | 0.010 |
Creatinine, µmol/l | 50 ± 1 | 45 ± 2 | 47 ± 2 | 49 ± 12 | 0.941 |
Total protein, g/l | 47 ± 3 | 48 ± 2 | 47 ± 1 | 44 ± 1 | 0.283 |
Urea, mmol/l | 7.6 ± 0.5 | 8.8 ± 0.6 | 8.8 ± 0.4 | 8.3 ± 0.5 | 0.379 |
Uric acid, µmol/l | 253 ± 39 | 283 ± 36 | 223 ± 18 | 230 ± 16 | 0.262 |
Ammonia, µmol/l | 840 ± 7 | 857 ± 6 | 854 ± 6 | 859 ± 14 | 0.472 |
CK, U/l | 133 ± 34 | 192 ± 38 | 273 ± 60a | 224 ± 22a | 0.015 |
CK-MB, U/l | 433 ± 105 | 606 ± 94 | 817 ± 160a | 688 ± 62a | 0.012 |
ALT, U/l | 52 ± 4 | 83 ± 16 | 68 ± 11 | 61 ± 10 | 0.289 |
AST, U/l | 96 ± 3 | 157 ± 23 | 146 ± 24 | 128 ± 14 | 0.170 |
Bilirubin, µmol/l | 5.2 ± 0.6 | 7.8 ± 1.4a | 8.6 ± 1.1a | 6.1 ± 0.7 | 0.036 |
TAS, mmol/l | 1.9 ± 0.08 | 2.1 ± 0.09 | 2.1 ± 0.04 | 2.0 ± 0.04 | 0.363 |
TAG: triacylglycerols; HDL: high-density lipoprotein; LDL: low-density lipoprotein; CK: creatine kinase; CK-MB: MB-fraction of creatine kinase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; TAS: total antioxidant status.
Differs from the controls (generalized linear model, P < 0.05).